News

October 16, 2017

Breast Cancer Death Rates Drop, but Racial Disparities Remain, American Cancer Society Reports

Advances in medicine have significantly lowered death rates in women with breast cancer, but black women are still more likely to die of the disease than white women, according ... Read more

October 13, 2017

First Breast Cancer Patient in Japanese Trial Receives Entinostat

News

The first patient has been dosed in a pivotal Phase 2 clinical trial in Japan evaluating entinostat as a therapy for hard-to-treat breast cancers. Syndax Pharmaceuticals, which developed the therapy, said the trial ... Read more

October 11, 2017

Researchers Develop New Strategy to Target Breast Cancer Metastasis in Bones

News

A new method using small particles loaded with chemotherapy drugs is a viable approach to target breast cancer cells that have spread to the bones, according to a report ... Read more

October 9, 2017

Synergys Awarded NCI Grant to Develop SYN001 for Triple-negative Breast Cancer

News

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded Synergys Biotherapeutics a grant to support the development of its antibody fusion molecule SYN001 for the treatment of triple negative breast ... Read more

October 6, 2017October 6, 2017

The Angelina Jolie Effect Was Real, Hard Data in US and Australia Confirms

News

Healthcare professionals have speculated for some time that Angelina Jolie’s decision to have a mastectomy in 2013 to reduce her risk of developing breast cancer prompted a lot of other ... Read more

October 4, 2017

Physical Activity Boosts Breast Cancer Survivors’ Cognition, Study Reports

News

When breast cancer survivors increased their physical activity, they more than doubled their mental processing speed, according to a study at the University of California San Diego School of ... Read more

October 2, 2017

FDA Approves Eli Lilly’s Verzenio for Certain Types of Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Verzenio (abemaciclib) for the treatment of HR-positive, HER2-negative type of advanced or metastatic breast cancer if ... Read more

September 29, 2017September 29, 2017

Nerlynx Delays Invasive Disease in Breast Cancer Patients Treated with Herceptin, ExteNET Trial Shows

News

Researchers found an increase in invasive disease-free survival (iDFS) in patients with early-stage breast cancer treated with Puma Biotechnology’s Nerlynx (neratinib) after initial treatment with Herceptin (trastuzumab). Quality of life ... Read more

September 27, 2017

Novartis, Eva Longoria Launch ‘Kiss This 4 MBC’ to Raise Funds, Awareness for Metastatic Breast Cancer

News

Novartis is teaming up with actress, producer, and activist Eva Longoria to launch “Kiss This 4 MBC” – a new funding and awareness-raising campaign to support the metastatic breast ... Read more

September 25, 2017

Tibetan Yoga May Improve Sleep Quality in Breast Cancer Patients on Chemotherapy, Study Finds

News

Practicing Tibetan yoga frequently may improve sleep quality in breast cancer patients receiving chemotherapy, research from The University of Texas MD Anderson Cancer Center shows. The study, “Randomized trial ... Read more